PANews reported on October 9th that according to PR Newswire, Leap Therapeutics (NASDAQ: LPTX), a biotechnology company, announced that it has completed its previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to launch its digital asset finance strategy. Winklevoss Capital will provide financial and strategic support to help Leap build and execute its digital asset finance strategy.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact
[email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.